BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37288817)

  • 1. De nove Philadelphia chromosome-positive myelodysplastic syndromes with complex karyotype and p230
    Ma J; Guan J; Chen B
    Hematology; 2023 Dec; 28(1):2220220. PubMed ID: 37288817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report and literature review.
    Li Y; Zhang Y; Meng X; Chen S; Wang T; Zhang L; Ma X
    Medicine (Baltimore); 2024 Jan; 103(3):e36728. PubMed ID: 38241589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation.
    Oshikawa G; Kurosu T; Arai A; Murakami N; Miura O
    Cancer Genet Cytogenet; 2010 May; 199(1):56-61. PubMed ID: 20417871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late appearance of Philadelphia chromosome with the p190 BCR/ABL chimeric transcript in acute myelogenous leukemia progressing from myelodysplastic syndrome.
    Kakihana K; Mizuchi D; Yamaguchi M; Sakashita C; Fukuda T; Yamamoto K; Miki T; Murakami N; Miura O
    Rinsho Ketsueki; 2003 Apr; 44(4):242-8. PubMed ID: 12784657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Philadelphia chromosome- positive myelodysplastic syndrome with single lineage dysplasia.
    Kumar A; Tilak V; Arora D; Marisha ; Rahul ; Gautam D; Ali A
    Cancer Genet; 2023 Aug; 276-277():12-16. PubMed ID: 37267684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
    Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR-ABL1: A report of three cases from India.
    Sazawal S; Chikkara S; Singh K; Chaubey R; Chandra D; Mishra P; Mahapatra M; Seth T; Saxena R
    Ann Diagn Pathol; 2017 Apr; 27():24-27. PubMed ID: 28325357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chronic myeloid leukemia patient with atypical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement.
    Masuko M; Furukawa T; Abe T; Wada R; Maruyama S; Kitajima T; Shibasaki Y; Toba K; Okada M; Aizawa Y
    Int J Hematol; 2009 Sep; 90(2):230-234. PubMed ID: 19565180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
    Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABL.
    Onozawa M; Fukuhara T; Takahata M; Yamamoto Y; Miyake T; Maekawa I
    Ann Hematol; 2003 Sep; 82(9):593-5. PubMed ID: 12898186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P230 BCR/ABL protein may be associated with an acute leukaemia phenotype.
    Haskovec C; Ponzetto C; Polák J; Maritano D; Zemanová Z; Serra A; Michalová K; Klamová H; Cermák J; Saglio G
    Br J Haematol; 1998 Dec; 103(4):1104-8. PubMed ID: 9886327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia.
    Wang L; Zhu K; Zha X; Chen S; Yang L; Chen S; Li Y
    J Hematol Oncol; 2010 Apr; 3():14. PubMed ID: 20377918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of common BCR-ABL fusion transcripts and their impact on treatment response in Imatinib treated CML patients: A study from India.
    Sazawal S; Chhikara S; Singh K; Chaubey R; Mahapatra M; Seth T; Saxena R
    Indian J Pathol Microbiol; 2019; 62(2):256-260. PubMed ID: 30971550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
    Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A
    BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in north Indian chronic myeloid leukemia patients.
    Mir R; Ahmad I; Javid J; Zuberi M; Yadav P; Shazia R; Masroor M; Guru S; Ray PC; Gupta N; Saxena A
    Indian J Cancer; 2015; 52(3):314-8. PubMed ID: 26905124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of chronic myeloid leukemia presenting with isolated thrombocytosis and complex Philadelphia chromosome: A case report.
    Gao L; Ren MQ; Tian ZG; Peng ZY; Shi G; Yuan Z
    Medicine (Baltimore); 2021 Sep; 100(35):e27134. PubMed ID: 34477162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare e14a3 (b3a3) BCR-ABL fusion in chronic myeloid leukemia in India: the threats and challenges in monitoring minimal residual disease (MRD).
    Vaniawala S; Acharya A; Parekh H; Mukhopadhyaya PN
    Anal Cell Pathol (Amst); 2013; 36(3-4):85-92. PubMed ID: 24072036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia.
    Manley R; Cochrane J; McDonald M; Rigby S; Moore A; Kirk A; Clarke S; Crossen PE; Morris CM; Patton WN
    Leukemia; 1999 Jan; 13(1):126-9. PubMed ID: 10049047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F; Bris MJ; Herry A; Calvez GL; Marion V; Abgrall JF; Berthou C; Braekeleer MD
    Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular monitoring of response to imatinib (Glivec) in chronic myeloid leukemia patients: experience at a tertiary care hospital in Saudi Arabia.
    Khalil SH; Abu-Amero KK; Al Mohareb F; Chaudhri NA
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):67-74. PubMed ID: 19943786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.